Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00307905

TRAUMEEL for Pain After Fracture of Neck of Femur

A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Post-operative Pain After Fracture of Neck of Femur

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
224 (estimated)
Sponsor
Shaare Zedek Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We hypothesize that Traumeel S is more effective than placebo in reducing 48-hour mean cumulative morphine consumption in patients scheduled for surgical correction of fracture of neck of hip. 224 patients, meeting all inclusion and none of exclusion criteria, will be enrolled in the trial. Patients will be randomized to receive either intraoperative injection and post operative oral Traumeel S Tablets or placebo injection (normal saline) and indistinguishable oral placebo tablets. Baseline measurements of relevant outcome measures will taken preoperatively. Immediately after surgery, patients will receive an initial dose of morphine of 0.1mg/kg body weight. Patients will take the oral study medication for 21 days. Every four hours after surgery, patients will be asked to grade their pain on an NRS. Subsequent doses of morphine will be calculated based upon the patient's weight and current NRS, according to a preplanned scheme. Patients will be permitted to request additional morphine, beyond their calculated dose.

Conditions

Interventions

TypeNameDescription
DRUGTraumeel Shomeopathic remedy
DRUGPlacebo remedyidentical size, shape and taste of treatment medication

Timeline

Start date
2011-01-01
Primary completion
2012-06-01
First posted
2006-03-28
Last updated
2010-10-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00307905. Inclusion in this directory is not an endorsement.